Related Experiment Video
Updated: May 18, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion
Moanaro Biswas1, John B Johnson, Sandeep R P Kumar
1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Abstract:
Newcastle disease virus (NDV), an avian paramyxovirus, is inherently tumor selective and is currently being considered as a clinical oncolytic virus and vaccine vector. In this study, we analyzed the effect of complement on the neutralization of NDV purified from embryonated chicken eggs, a common source for virus production. Fresh normal human serum (NHS) neutralized NDV by multiple pathways of complement activation, independent of neutralizing antibodies. Neutralization was associated with C3 deposition and the activation of C2, C3, C4, and C5 components. Interestingly, NDV grown in mammalian cell lines was resistant to complement neutralization by NHS. To confirm whether the incorporation of regulators of complement activity (RCA) into the viral envelope afforded complement resistance, we grew NDV in CHO cells stably transfected with CD46 or HeLa cells, which strongly express CD46 and CD55. NDV grown in RCA-expressing cells was resistant to complement by incorporating CD46 and CD55 on virions. Mammalian CD46 and CD55 molecules on virions exhibited homologous restriction, since chicken sera devoid of neutralizing antibodies to NDV were able to effectively neutralize these virions. The incorporation of chicken RCA into NDV produced in embryonated eggs similarly provided species specificity toward chicken sera.
Insights
Newcastle disease virus (NDV) grown in mammalian cells resists complement neutralization. Incorporating regulators of complement activity (RCA) into NDV provides species-specific resistance, impacting its use as an oncolytic virus.
Area of Science:
- Virology
- Immunology
- Oncolytic Virus Therapy
Background:
- Newcastle disease virus (NDV) is an avian paramyxovirus with inherent tumor selectivity, making it a candidate for oncolytic virotherapy and vaccine vectors.
- Understanding virus-host interactions, particularly complement system effects, is crucial for optimizing NDV's clinical application.
Purpose of the Study:
- To investigate the impact of complement activation on NDV neutralization.
- To determine if NDV grown in different cell types affects its susceptibility to complement-mediated lysis.
- To explore the role of regulators of complement activity (RCA) in conferring complement resistance to NDV.
Main Methods:
- NDV was purified from embryonated chicken eggs and grown in mammalian cell lines (CHO, HeLa) engineered to express RCA (CD46, CD55).
- Neutralization assays were performed using normal human serum (NHS) and chicken sera.
- Complement component deposition (C3) and activation pathways were analyzed.
Main Results:
- Fresh NHS effectively neutralized NDV from embryonated eggs via complement activation (C3, C4, C5), independent of antibodies.
- NDV grown in mammalian cell lines, particularly those expressing RCA (CD46, CD55), exhibited resistance to complement neutralization by NHS.
- Incorporation of mammalian RCA (CD46, CD55) conferred resistance, but these molecules also induced homologous restriction, allowing chicken sera to neutralize RCA-expressing NDV.
- Chicken RCA incorporation into NDV produced in eggs also conferred species-specific resistance to chicken sera.
Conclusions:
- Complement system plays a significant role in neutralizing NDV produced in embryonated eggs.
- NDV's complement susceptibility is dependent on its production system, with mammalian cell-derived viruses showing resistance due to RCA incorporation.
- Engineering NDV with specific RCA can modulate its species-specific complement resistance, offering potential strategies for therapeutic applications.
Related Concept Videos
Complement System
Regulation of Bacterial Virulence
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
Inhibitors of Viral Protein Synthesis
Regulation of Nuclear Protein Sorting

